NCT00662220 - High-dose Ribavirin in Treatment of Chronic Hepatitis C Genotype 1 or 4 | Biotech Hunter

Enrollment

110

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

June 30, 2013

Study Completion Date

November 30, 2013

Conditions

Chronic Hepatitis C

Interventions

DRUG

ribavirin

25-29 mg/kg/day

DRUG

ribavirin

12-15 mg/kg/day

Trial Locations (27)

3200

Walcheren hospital, Flushing

6815AD

Rijnstate, Arnhem

6525GA

St. Radboud University Medical Center, Nijmegen

6532 SZ

Canisius-Wilhelmina Ziekenhuis, Nijmegen

6401CX

Atrium Medisch Centrum, Heerlen

4818CK

Amphia hospital, Breda

5602ZA

Catharina hospital, Eindhoven

5000LA

Twee Steden hospital, Tilburg

5000LC

St. Elisabeth hospital, Tilburg

1815JD

Medisch Centrum Alkmaar, Alkmaar

1006BK

Slotervaart hospital, Amsterdam

1007 MB

VU Medisch Centrum, Amsterdam

1090HM

Onze Lieve Vrouwen Gasthuis, Amsterdam

2130 AT

Spaarne Ziekenhuis, Hoofddorp

7415CM

Deventer hospital, Deventer

9713GZ

Groningen University Medical Center, Groningen

9670RA

St. Lucas hospital, Winschoten

2906ZC

IJsselland hospital, Capelle aan den IJssel

2600GA

Reinier de Graaf Gasthuis, Delft

3300AK

Albert Schweitzer hospital, Dordrecht

2300 RC

Leids Universitair Medisch Centrum, Leiden

3004BA

St Franciscus hospital, Rotterdam

3015CE

Erasmus MC University Medical Center, Rotterdam

3078HT

Maasstad hospital, Rotterdam

2545CH

HAGA Ziekenhuis, The Hague

3584CX

Universitair Medisch Centrum Utrecht, Utrecht

4535PA

ZorgSaam Hospital, Terneuzen